Manufacturers of vaccines against coronavirus disease (Covid-19) should be protected from liability in the event of serious adverse reactions or other claims to their vaccines during a pandemic, said the executive director of the Serum Institute of India (SII). ), Adar Poonawalla. Poonawalla, who made the remarks during a virtual …
Read More »
The Ministry of Health said that the COVID-19 vaccine will be voluntary, but registration is mandatory New Delhi: Getting vaccinated against COVID-19 will be voluntary, the Union Health Ministry said, while stressing that the vaccine introduced in India will be as effective as any vaccine developed by other countries. The …
Read More »
By: Express Web Desk | New Delhi | Updated: December 16, 2020 8:58:24 pm Prime Minister Narendra Modi receives briefing during a visit to the Bharat Biotech facility (archive) The Covid-19 vaccine indigenously developed by Bharat Biotech has been found to be well tolerated in all dose groups with no …
Read More »
NEW DELHI: The Center on Monday released detailed guidelines for India’s mass vaccination campaign that will begin once the lead candidates, some of whom are under regulatory review, are available for emergency use. In phase one of the vaccination campaign, the government plans to vaccinate nearly 30 million people, including …
Read More »
BENGALURU: Overall global orders to secure vaccines fell by 19.2 million doses to 7.1 billion as of December 11, compared to 7.12 million as of November 30. India, which had deals for 1.6 billion doses at the end of last month, has 1.5 billion according to data from Duke University’s …
Read More »
NEW DELHI: A committee of experts from the Central Drug Standard Control Organization (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates from Serum Institute and Bharat Biotech, after deliberating on their applications to obtain an emergency use authorization for injections. official sources said. The request …
Read More »
Drug Controller Likely to Take AstraZeneca Emergency Use Call, Pfizer’s COVID-19 Vaccinations in 2 weeks The Comptroller General of Drugs of India has started to process applications submitted by Pfizer Inc and Serum Institute of India to grant emergency use authorization to their COVID-19 vaccinations and is likely to make …
Read More »
NEW DELHI / BENGALURU: India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world’s second-worst affected country struggles to contain the outbreak. The Indian government is pinning its hopes of mass supply of …
Read More »
India has become the largest buyer of confirmed vaccine doses with 1.6 billion as countries are securing vaccines to fight the coronavirus disease (Covid-19), which has already killed 1.5 million people across the world. world, a study by Duke University showed in the US India has so far registered more …
Read More »
By: Desk Explained | New Delhi | Updated: December 3, 2020 6:38:57 pm The Oxford vaccine for Covid-19 is AZD1222. Late last month, Oxford and AstraZeneca said their vaccine candidate for COVID-19, AZD1222, could be as effective as 90 percent when given as a half dose followed by a full …
Read More »